A High-Efficiency Synthetic Promoter That Drives Transgene Expression Selectively in Noradrenergic Neurons
- 20 September 2001
- journal article
- Published by Mary Ann Liebert Inc in Human Gene Therapy
- Vol. 12 (14) , 1731-1740
- https://doi.org/10.1089/104303401750476230
Abstract
Gene promoter systems that drive high-level, long-term, and cell-specific transgene expression are of great interest because of their potential utility for gene therapy. To generate an efficient promoter system specific for noradrenergic (NA) neurons, we multimerized an NA-specific cis-regulatory element (PRS2) identified in the human dopamine beta-hydroxylase (hDBH) promoter, and combined it with a minimal promoter (containing a TATA box and transcription start site). Forms of this synthetic promoter that contain 8 or more copies of PRS2 were >50 times more effective than the 1.15-kb hDBH promoter at driving reporter gene expression in cell lines originated from NA neurons. Neither the synthetic promoter nor the 1.15-kb hDBH promoter drove reporter gene expression in nonneuronal cells. Microinjections of an adenoviral vector containing the synthetic promoter directly into rat brain caused more strict NA-specific reporter gene expression than that caused by a vector containing the 1.15-kb hDBH promoter when the targeted region contained large numbers of NA neurons (locus coeruleus). Furthermore, the vector containing the synthetic promoter caused less nonspecific ("leaky") reporter gene expression than that caused by the vector containing the 1.15-kb hDBH promoter when the targeted region was devoid of NA neurons (cerebellum, dentate gyrus). Together, these studies provide in vitro and in vivo evidence that this novel synthetic promoter can target transgene expression to NA neurons even more efficiently and selectively than the naturally occurring, 1.15-kb hDBH promoter.Keywords
This publication has 32 references indexed in Scilit:
- Gene therapy in the CNSGene Therapy, 2000
- Diverse Stabilities of Expression in the Rat Brain from Different Cellular Promoters in a Helper Virus-Free Herpes Simplex Virus Type 1 Vector SystemHuman Gene Therapy, 1999
- Paired‐Like Homeodomain Proteins, Phox2a and Phox2b, Are Responsible for Noradrenergic Cell‐Specific Transcription of the Dopamine β‐Hydroxylase GeneJournal of Neurochemistry, 1998
- Defects in Sensory and Autonomic Ganglia and Absence of Locus Coeruleus in Mice Deficient for the Homeobox Gene Phox2aNeuron, 1997
- NEURONAL-SPECIFIC GENE EXPRESSION μ THE INTERACTION OF BOTH POSITIVE AND NEGATIVE TRANSCRIPTIONAL REGULATORSProgress in Neurobiology, 1996
- Under Siege: The Brain on OpiatesNeuron, 1996
- A model system for in vivo gene transfer into the central nervous system using an adenoviral vectorNature Genetics, 1993
- Analysis of the Human Dopamine β‐Hydroxylase Promoter: Transcriptional Induction by Cyclic AMPJournal of Neurochemistry, 1993
- The dopamine β-hydroxylase gene promoter directs expression of E. coli lacZ to sympathetic and other neurons in adult transgenic miceNeuron, 1991
- Dopamine beta-hydroxylase deficiency. A genetic disorder of cardiovascular regulation.Hypertension, 1991